Episode 9: Zogenix, Inc.'s Dawn Blessing and J. Michael Graglia from SynGAP

Episode 9 • September 01, 2021 • 00:47:27
Episode 9:  Zogenix, Inc.'s Dawn Blessing and J. Michael Graglia from SynGAP
Few & Far Between: How Biotech Gets Built
Episode 9: Zogenix, Inc.'s Dawn Blessing and J. Michael Graglia from SynGAP

Sep 01 2021 | 00:47:27

/

Show Notes

Tune in for today's full episode of Few & Far Between. Episode 9 features Biorasi's Becky Knockemus, Zogenix, Inc.'s Dawn Blessing, and J. Michael Graglia from SynGAP Research Fund, discussing the importance of diagnosing #raredisease early and the critical step of sharing study data.

Other Episodes

Episode 11

September 28, 2021 • 00:34:38
Episode Cover

Episode 11: Rebecca Stewart and Nicola Miller from Rare Revolution Magazine

How important is transparency to the rare disease community? Today's full episode of Few & Far Between features Biorasi's Lindsey Rios, with guests Rebecca...

Listen

Episode 37

January 24, 2024 • 00:41:31
Episode Cover

Episode 37: Will Greene, Prader-Willi Syndrome patient advocate, Healthcare Engagement Lead at Roche

"The history of rare disease drug development indicates that once you start looking harder for cases, you often tend to find them." - Will...

Listen

Episode 65

November 24, 2025 • 01:06:51
Episode Cover

Video Episode 65 - Amit Etkin, Founder and CEO of Alto Neuroscience

With biotech, is it the destination, the journey, or both? Find out in a new episode of the Biorasi Few & Far Between podcast....

Listen